
 Nye Health’s digital platform will be coupled with the patient support experience available at Inizio Engage. The integrated approach will …

Clinical stage oncology firm Oxford BioTherapeutics has signed a deal with the open-access biologics technology platform company WuXi Biologics, in …

Several pharma companies have announced new collaborations, to research potential new drugs for Crohn’s disease, and immuno-oncology treatments for cancer. …
Janssen has signed a deal with Forma Therapeutics to discover, and develop drugs that target tumour metabolism mechanisms.Forma focuses on …
These days no pharmaceutical company would be caught admitting that they did not have an alliance strategy. After all, the …
Five Facts about cardiovascular disease
Artificial hearts: a century of innovation

